# Rectal metastasis in a patient with long-term breast cancer: a rare case report with literature review

**Authors:** Xiaohong Lyu, Feng Mao

PMC · DOI: 10.3389/fonc.2026.1597103 · Frontiers in Oncology · 2026-01-21

## TL;DR

A breast cancer patient developed rare rectal metastasis seven years after initial diagnosis, highlighting the need for vigilance in long-term follow-up.

## Contribution

This case report adds to the limited literature on rectal metastasis from breast cancer and emphasizes its delayed occurrence.

## Key findings

- Rectal metastasis occurred seven years after initial breast cancer diagnosis.
- Immunohistochemistry showed GATA3(+) and loss of hormone receptor expression in the metastatic tumor.
- The case highlights the importance of considering GI metastasis in patients with bowel symptoms.

## Abstract

Gastrointestinal (GI) metastases from breast cancer are uncommon, with rectal involvement being particularly rare. Here, we present a case of a 55-year-old female with a history of bilateral breast cancer who developed rectal metastasis seven years after initial diagnosis. The patient was initially diagnosed in 2017 with left breast invasive ductal carcinoma (IDC) and right breast ductal carcinoma in situ (DCIS). Despite receiving comprehensive treatment, including modified radical mastectomy, chemotherapy, radiotherapy, and endocrine therapy, she experienced multiple metastases involving the bones, lymph nodes, and pleura. In 2024, she presented with new bowel symptoms, and colonoscopy revealed rectal wall thickening with stenosis. Biopsy confirmed metastatic breast cancer with immunohistochemistry showing GATA3(+), CDX2(-), and loss of hormone receptor expression compared to the primary tumor. This case underscores the importance of considering gastrointestinal metastasis in breast cancer patients with bowel symptoms, even years after initial treatment. We also review the literature regarding the literature on the diagnosis, treatment, and prognosis of breast cancer rectal metastasis.

## Linked entities

- **Proteins:** GATA3 (GATA binding protein 3), CDX2 (caudal type homeobox 2)
- **Diseases:** breast cancer (MONDO:0004989), invasive ductal carcinoma (MONDO:0004953), ductal carcinoma in situ (MONDO:0005023)

## Full-text entities

- **Genes:** GATA3 (GATA binding protein 3) [NCBI Gene 2625] {aka HDR, HDRS}, CDX2 (caudal type homeobox 2) [NCBI Gene 1045] {aka CDX-3, CDX2/AS, CDX3}
- **Diseases:** breast cancer (MESH:D001943), IDC (MESH:D044584), Gastrointestinal (GI) metastases (MESH:D009362), DCIS (MESH:D002285), tumor (MESH:D009369), stenosis (MESH:D003251)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12867834/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12867834/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12867834/full.md

---
Source: https://tomesphere.com/paper/PMC12867834